FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
Biological markers that could predict the progression of ductal carcinoma in-situ (DCIS) to invasive breast cancer (IDC) are required urgently for personalized therapy for patients diagnosed with DCIS. As stroma was invaded by malignant cells, perturbed stromal-epithelial interactions would bring ab...
Main Authors: | Li-Na Yu, Zhen Liu, Yan Tian, Pei-Pei Zhao, Xing Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01424/full |
Similar Items
-
Is palpable DCIS more aggressive than screen-detected DCIS?
by: Nina Balac, et al.
Published: (2023-01-01) -
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
by: Hongying Liu, et al.
Published: (2018-06-01) -
A low risk of recurrence after breast-conserving surgery for DCIS: A single-institution experience
by: Sara van Bekkum, et al.
Published: (2023-01-01) -
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
by: Li Huan, et al.
Published: (2012-08-01) -
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness
by: Ze-Yi Zheng, et al.
Published: (2022-10-01)